MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by advanced AI and machine learning. This shift is centered on pharmacogenomics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results